Hypertension, Vol 5, 535-538, Copyright © 1983 by American Heart Association
PC Rubin, K McLean and JL Reid
We describe two studies designed to elucidate the role of endogenous
opioids in blood pressure control in humans. In the first study, nine
normal subjects received infusions of DAMME (a metenkephalin analog),
naloxone, or saline, and blood pressure, heart rate, and plasma
norepinephrine concentration were determined supine and following 5 minutes
of 70 degrees head-up tilt at intervals for 6 hours. Blood pressure
following tilt was significantly decreased by DAMME but not influenced by
naloxone, the effect being most marked at 3 hours (placebo = 110 +/- 6/78
+/- 7 mm Hg; naloxone = 106 +/- 10/79 +/- 5 mm Hg; DAMME = 96 +/- 16/67 +/-
8 mm Hg (p less than 0.01). However, heart rate and plasma norepinephrine
did not rise in response to this hypotension. Heart rates at 3 hours were:
placebo = 87 +/- 16 bpm; naloxone = 88 +/- 19 bpm; DAMME = 89 +/- 23 bpm.
Plasma norepinephrine levels (nmol/liter) at 3 hours were: placebo = 6.0
+/- 2.2; naloxone = 5.8 +/- 1.9; DAMME = 6.0 +/- 1.9. In the second study,
seven normal subjects had blood pressure reduced by incremental infusions
of sodium nitroprusside, and the effects of placebo, naloxone, and DAMME on
the slope of the heart period/blood pressure relationship investigated.
Naloxone significantly increased the slope by 90% and DAMME significantly
reduced the slope by 30%. It is concluded that endogenous opioids modulate
the baroreflex control of blood pressure in normal humans.
ARTICLES
Endogenous opioids and baroreflex control in humans
This article has been cited by other articles:
![]() |
P. Kienbaum, T. Heuter, M. C. Michel, N. Scherbaum, M. Gastpar, and J. Peters Chronic {micro}-Opioid Receptor Stimulation in Humans Decreases Muscle Sympathetic Nerve Activity Circulation, February 13, 2001; 103(6): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zoccali Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease? Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1919 - 1921. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |